Clinical Trials Browser

Active not recruiting × Urinary Bladder Neoplasms × camrelizumab × Clear all

NCT04706598 2024-07-12

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Phase 1/2 Active not recruiting

Urinary Bladder Neoplasms